Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Subclinical and clinical chorioamnionitis, fetal vasculitis, and risk for preterm birth: A cohort study.

Palmsten K, Nelson KK, Laurent LC, Park S, Chambers CD, Parast MM.

Placenta. 2018 Jul;67:54-60. doi: 10.1016/j.placenta.2018.06.001. Epub 2018 Jun 6.

PMID:
29941174
2.

Revisiting the Table 2 fallacy: A motivating example examining preeclampsia and preterm birth.

Bandoli G, Palmsten K, Chambers CD, Jelliffe-Pawlowski LL, Baer RJ, Thompson CA.

Paediatr Perinat Epidemiol. 2018 Jul;32(4):390-397. doi: 10.1111/ppe.12474. Epub 2018 May 21.

PMID:
29782045
3.

In vitro fertilization, interpregnancy interval, and risk of adverse perinatal outcomes.

Palmsten K, Homer MV, Zhang Y, Crawford S, Kirby RS, Copeland G, Chambers CD, Kissin DM, Su HI; States Monitoring Assisted Reproductive Technology (SMART) Collaborative.

Fertil Steril. 2018 May;109(5):840-848.e1. doi: 10.1016/j.fertnstert.2018.01.019.

PMID:
29778383
4.

Making the best use of data not created for research.

Palmsten K, Chambers CD.

Paediatr Perinat Epidemiol. 2018 May;32(3):287-289. doi: 10.1111/ppe.12466. Epub 2018 Mar 25. No abstract available.

PMID:
29575116
5.

Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose.

Palmsten K, Rolland M, Hebert MF, Clowse MEB, Schatz M, Xu R, Chambers CD.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):430-438. doi: 10.1002/pds.4410. Epub 2018 Feb 28.

PMID:
29488292
6.

Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period.

Bandoli G, Kuo GM, Sugathan R, Chambers CD, Rolland M, Palmsten K.

Arch Womens Ment Health. 2018 Aug;21(4):411-419. doi: 10.1007/s00737-018-0809-2. Epub 2018 Jan 16.

PMID:
29340802
7.

Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma.

Palmsten K, Hulugalle A, Bandoli G, Kuo GM, Ansari S, Xu R, Chambers CD.

Paediatr Perinat Epidemiol. 2018 Jan;32(1):68-77. doi: 10.1111/ppe.12415. Epub 2017 Oct 3.

8.

A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes.

Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD.

Rheum Dis Clin North Am. 2017 Aug;43(3):489-502. doi: 10.1016/j.rdc.2017.04.013. Review.

9.

Most Frequently Reported Prescription Medications and Supplements in Couples Planning Pregnancy: The LIFE Study.

Palmsten K, Flores KF, Chambers CD, Weiss LA, Sundaram R, Buck Louis GM.

Reprod Sci. 2018 Jan;25(1):94-101. doi: 10.1177/1933719117702249. Epub 2017 Apr 12.

10.

Medication use among pregnant women with systemic lupus erythematosus and general population comparators.

Palmsten K, Simard JF, Chambers CD, Arkema EV.

Rheumatology (Oxford). 2017 Apr 1;56(4):561-569. doi: 10.1093/rheumatology/kew448.

11.

Early-onset Preeclampsia in Lupus Pregnancy.

Simard JF, Arkema EV, Nguyen C, Svenungsson E, Wikström AK, Palmsten K, Salmon JE.

Paediatr Perinat Epidemiol. 2017 Jan;31(1):29-36. doi: 10.1111/ppe.12332. Epub 2016 Dec 12.

12.

What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population-Based Study of Maternal and Fetal Outcomes in SLE and Pre-SLE.

Arkema EV, Palmsten K, Sjöwall C, Svenungsson E, Salmon JE, Simard JF.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):988-94. doi: 10.1002/acr.22791.

13.

Constructing Causal Diagrams for Common Perinatal Outcomes: Benefits, Limitations and Motivating Examples with Maternal Antidepressant Use in Pregnancy.

Bandoli G, Palmsten K, Flores KF, Chambers CD.

Paediatr Perinat Epidemiol. 2016 Sep;30(5):521-8. doi: 10.1111/ppe.12302. Epub 2016 May 10.

14.

Validation of the Pregnancy Asthma Control Test.

Palmsten K, Schatz M, Chan PH, Johnson DL, Chambers CD.

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):310-5.e1. doi: 10.1016/j.jaip.2015.11.019. Epub 2016 Jan 5.

15.

The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program.

Palmsten K, Hernández-Díaz S, Chambers CD, Mogun H, Lai S, Gilmer TP, Huybrechts KF.

Obstet Gynecol. 2015 Sep;126(3):465-73. doi: 10.1097/AOG.0000000000000982.

16.

Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.

Swanson SA, Hernandez-Diaz S, Palmsten K, Mogun H, Olfson M, Huybrechts KF.

Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):934-42. doi: 10.1002/pds.3798. Epub 2015 Jun 4.

17.

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.

Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S.

JAMA. 2015 Jun 2;313(21):2142-51. doi: 10.1001/jama.2015.5605.

18.

Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results.

Margulis AV, Palmsten K, Andrade SE, Charlton RA, Hardy JR, Cooper WO, Hernández-Díaz S.

Pharmacoepidemiol Drug Saf. 2015 Apr;24(4):335-42. doi: 10.1002/pds.3743. Epub 2015 Jan 28. Review.

PMID:
25627986
19.

Antidepressant use in pregnancy and the risk of cardiac defects.

Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.

N Engl J Med. 2014 Jun 19;370(25):2397-407. doi: 10.1056/NEJMoa1312828.

20.

Validity of maternal and infant outcomes within nationwide Medicaid data.

Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernández-Díaz S.

Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):646-55. doi: 10.1002/pds.3627. Epub 2014 Apr 16.

Supplemental Content

Loading ...
Support Center